McCallum Stewart
Insider CIK 1659872 · REPH Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REPH Recro Pharma, Inc. | M Exercise deriv | 2018-01-18 | 2018-01-22 | 6,000 | — | $0 | 18,000 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2018-01-18 | 2018-01-22 | 1,860 | $8.89 | $16.5K | 31,841 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2018-01-18 | 2018-01-22 | 6,000 | — | $0 | 33,701 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2018-01-02 | 2018-01-04 | 32,200 | — | $0 | 32,200 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2018-01-02 | 2018-01-04 | 16,100 | — | $0 | 27,701 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2017-09-28 | 2017-10-02 | 15,000 | — | $0 | 16,250 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2017-09-28 | 2017-10-02 | 4,649 | $9.04 | $42.0K | 11,601 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-01-18 | 2017-01-20 | 24,000 | — | $0 | 24,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-01-18 | 2017-01-20 | 36,000 | — | $0 | 36,000 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2016-05-31 | 2016-05-31 | 250 | $8.50 | $2.1K | 1,250 | SEC↗ |
| REPH Recro Pharma, Inc. | P Buy | 2016-05-26 | 2016-05-31 | 1,000 | $8.15 | $8.2K | 1,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2015-12-01 | 2015-12-02 | 103,000 | — | $0 | 103,000 | SEC↗ |